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Background
Vertical transmission from HCV infected mothers seems
to be one of the main modes of infection in children.
Approximately 6% of hepatitis C virus-positive women
transmit HCV to their offsprings. There has been no infor-
mation about anti-HCV prevalence in pregnant women in
Poland to date. Routine universal antenatal screening for
hepatitis C infection has not been shown to be cost effec-
tive. Selective antenatal screening is used on the basis of
risk factors for exposure to HCV. There is no effective
intervention to prevent vertical transmission of HCV dur-
ing pregnancy, but HCV infection could be reduced by a
course of therapy prior to conception. Aim: 1. To deter-
mine the frequency of HCV infection in pregnant women
in central Poland 2. To estimate knowledge about HCV
infection in childbearing women. 3. To identify risk fac-
tors for HCV infection among pregnant women.
Methods
Study in two separate parts: Part I/: Blood samples were
collected from 544 pregnant women in central Poland
and tested with anti-HCV ELISA third-generation tests.
Part II/: Data of risk factors of HCV infection, reason of
diagnostics were assessed through structured interview
and review of available medical records in 281 women
infected with HCV who came to Department of Children's
Infectious Diseases to examine their infants for HCV
infection.
Results
Part I/Eleven pregnant women (2.02%) were infected
with HCV. One of them (1/11) knew about her infection
before examination. The seroprevalence varied by city/
country living (2.2% vs 1,0%). The mean age of tested
women was 29.9 years, infected women 29.8 years. Part
II/247(88%) infected women lived in cities, 34(12%) in
country. 24% indicate a history of blood products transfu-
sion (all before 1992), 23% surgical, gynaecological pro-
cedures, transplantations, 15% intravenous drug use, 8%
hospitalization without surgical procedures, 7% expo-
sures of health care personnel, 3% infected mother, 6%
other risk factors like: tattoos, sexual partner or other
member of family infected with HCV. Histories taken
from 14% women did not include any risk factors. HCV
infection in women were diagnosed: 186(66%) before
pregnancy, 61(22%) during pregnancy, 34(12%) after
delivery. 95/281(34%) did not know about their HCV
infection before pregnancy. All women were Caucasian,
Polish nationality.
Conclusion
The prevalence of anti-HCV in pregnant women in central
Poland is 2.02%. There is a number of childbearing HCV
infected women who are not identified as HCV positive.
Selective HCV testing to woman at high risk of HCV infec-
tion should be encouraged prior to conception. Following
the introduction of blood product screening (in Poland:
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anti-HCV in 1992, HCV-RNA RT-PCR 2001) – transfusion
has not been a possible route of HCV infection.
Detailed epidemiological anamnesis plays an important
role in the diagnostics, but not always allows identifying
the risk group.
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